Aspirin 0 7 0 7 B-chronic_disease
exacerbated 8 19 8 19 I-chronic_disease
respiratory 20 31 20 31 I-chronic_disease
disease 32 39 32 39 I-chronic_disease

CRSsNP 0 6 40 46 B-chronic_disease
as 7 9 47 49 O
defined 10 17 50 57 O
by 18 20 58 60 O
Clinical 21 29 61 69 O
Practice 30 38 70 78 O
Guideline 39 48 79 88 O
( 49 50 89 90 O
Update 50 56 90 96 O
) 56 57 96 97 O
on 58 60 98 100 O
Adult 61 66 101 106 O
Sinusitis 67 76 107 116 B-chronic_disease

Immunosuppressive 0 17 117 134 O
states 18 24 135 141 O
( 25 26 142 143 O
Human 26 31 143 148 B-chronic_disease
immunodeficiency 32 48 149 165 I-chronic_disease
virus 49 54 166 171 I-chronic_disease
, 54 55 171 172 O
transplant 56 66 173 183 B-treatment
) 66 67 183 184 O

Oral 0 4 185 189 B-treatment
steroid 5 12 190 197 I-treatment
use 13 16 198 201 O
within 17 23 202 208 O
30 24 26 209 211 B-upper_bound
days 27 31 212 216 I-upper_bound
of 32 34 217 219 O
surgery 35 42 220 227 B-treatment

chronic 0 7 228 235 B-chronic_disease
rhinosinusitis 8 22 236 250 I-chronic_disease
with 23 27 251 255 I-chronic_disease
polyps 28 34 256 262 I-chronic_disease
( 35 36 263 264 I-chronic_disease
CRSwNP 36 42 264 270 I-chronic_disease
) 42 43 270 271 I-chronic_disease

scheduled 0 9 272 281 O
to 10 12 282 284 O
undergo 13 20 285 292 O
endoscopic 21 31 293 303 B-treatment
sinus 32 37 304 309 I-treatment
surgery 38 45 310 317 I-treatment

